| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| R793308 | MACKLIN | 利培酮 | in 2mM DMSO | 520元/1ml; | 咨询 |
|
| R830745 | MACKLIN | 利培酮 | 99% | 58元/1g; 218元/5g; 940元/25g; 3740元/100g; | 咨询 |
|
| R0087 | TCI | Risperidone | >98.0%(T)(HPLC) | 1080元/50MG; 3795元/500MG; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C23H27FN4O2 = 410.49 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 4891881 | | PubChem物质ID | 125307687 | | Merck Index (14) | 8233 | | MDL编号 | MFCD00274576 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 170.0 to 174.0 ℃ |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 140636 | J&K | Risperidone | 99.5%, 多巴胺、5 -羟色胺、肾上腺素、组胺等受体拮抗剂 | 641元/50MG; 1472元/250mg; 2796元/5G; | 咨询 |
基本信息 | 分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | 熔点 | 170-174 | | MDL编码 | MFCD00274576 | | Beilstein | 4891881 | | Merck | 14,8233 | | 存储条件 | Freezer -20℃ | 产品描述 Risperidone 是一种多靶点的拮抗剂,作用于dopamine, serotonin, adrenergic and histamine receptors,用于治疗精神分裂症以及抑郁狂躁型忧郁症。 靶点(IC50 & Targe) 5-HT2A,0.17nM(Ki) D2,3.57nM(Ki) D2L,4.16nM(Ki) D3,3.6nM(Ki) α2C-adrenergic receptor,1.3nM(Ki) 体外研究 Risperidone结合DA和血清素(5HT)受体,特别是在纹状体和边缘结构的神经元中。Risperidone显著影响脑的神经生长因子(NGF)水平,表明它影响的内源生长因子的转化率。Risperidone显著降低额叶,枕叶皮层和海马中BDNF浓度,减少或增加在选定的大脑结构中的TrkB受体。[1]在大鼠前脑区域中,Risperidone显著增加D(2)在内侧前额叶皮质结合达34%。在大鼠前脑区域中,Risperidone上调额叶,枕叶皮层和海马中D(2)受体分别达37%,32%和37%。[2] 在活化的小胶质细胞中,Risperidone显著抑制NO和促炎细胞因子的产生。[3]在Caco-2细胞中,Risperidone (1-50 mM)通过抑制P-gp的活性显著增强Rh123的细胞内积累,IC(50)值为5.87 mM。[4] 体内研究 Risperidone不显著影响体重增益(BWG),食物摄取(FI),葡萄糖耐受性或瘦蛋白水平,虽然催乳素和皮质酮在雄性大鼠中显著升高。Risperidone显著增加雌性大鼠的BWG和FI。[5] 在白色脂肪组织(WAT)中,Risperidone(0.05 毫克/千克)增加食物摄取和瘦素基因表达,但体重增益率在大鼠中不受影响。Risperidone(0.5 毫克/千克)导致体重增益的减少,以及BAT中增强的UCP1基因表达,大鼠中血清催乳素浓度的增加。[6] 参考文献 [1] Angelucci F, et al. J Neurosci Res,?000, 60(6), 783-794. [2] Tarazi FI, et al. J Pharmacol Exp Ther,?001, 297(2), 711-717. [3] Kato T, et al. Schizophr Res,?007, 92(1-3), 108-115. [4] Zhu HJ, et al. Neuropsychopharmacology,?007, 32(4), 757-764. [5] Baptista T, et al. Brain Res,?002, 957(1), 144-151. 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H301 | | 防范说明 | P301+P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 3 | | RTECS | UV1164800 |
|
| PHR1631 | Supelco | Risperidone | Pharmaceutical Secondary Standard; Certified Reference Material | 2877.68元/500 MG; | 咨询 |
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案 利培酮是一种新的中枢 5-羟色胺 2 和多巴胺 D2 拮抗剂。它用于治疗痴呆期引起的激越、攻击行为和精神病。它是精神抑制药。它也是一种非典型抗精神病药物,用于治疗精神分裂症。 利培酮是一种精神药物,属于苯并异恶唑衍生物类化合物,通常用于治疗精神分裂症。 应用 利培酮可用作药物参考标准品,用于通过比色技术和反相高效液相色谱技术对药物制剂中的分析物进行定量。 这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。 分析说明 这些二级标准品可追溯至USP、EP和BP一级标准品(在它们可用的情况下)。 其他说明 本有证参考物质 (CRM) 按照 ISO 17034 和 ISO/IEC 17025 生产和认证。有关本 CRM 使用的所有信息,请参见分析证书。 附注 欲查看此物质的分析证书样本,请在下面的对话框中输入LRAC2895。这只是一个示例证书,可能与您收到的批次不符。 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | PubChem化学物质编号 | 329823521 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 1137 traceable to PhEur R1000600 traceable to USP 1604654 | | 储存温度 | 2-30℃ | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| R1000600 | | Risperidone | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia. 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | PubChem化学物质编号 | 329823994 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 + P330 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0000370 | | Risperidone for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | PubChem化学物质编号 | 329830925 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| R3030 | Sigma-Aldrich | Risperidone | ≥98% (HPLC), powder | 1746.67元/10 MG; 6233.79元/50 MG; | 咨询 |
产品说明 一般描述 利培酮是苯并异恶唑衍生物。它是多巴胺 D2、组胺 H1 和 α1 和 α2 肾上腺素能受体的拮抗剂。利培酮用于治疗精神分裂症、双相情感障碍和自闭症。 应用 利培酮可用于:
- 研究其对骨形成和分化的影响
- 研究利多酮(RIS)剂量与自闭症谱系障碍(ASD)儿童患者的血浆利多酮水平之间的关系
- 逆转诱导小鼠精神分裂症样行为
包装 10, 50 mg in glass bottle 生化/生理作用 利培酮是一种抗精神病药;血清素-多巴胺拮抗剂。 特点和优势 该化合物由 Johnson & Johnson 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处。 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | PubChem化学物质编号 | 329824020 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% (HPLC) | | 形式 | powder | | 颜色 | white to off-white | | 溶解性 | DMSO: ≥5 mg/mL | | 创始人 | Johnson & Johnson | | 储存温度 | room temp | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| BP1137 | | Risperidone | British Pharmacopoeia (BP) Reference Standard | 1952.55元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1604654 | USP | Risperidone | United States Pharmacopeia (USP) Reference Standard | 3231.47元/100 MG; | 咨询 |
产品说明 一般描述 Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia. 应用 It was used as reference standard during RP-UPLC analysis for determination of risperidone related compounds in Risperdal® Consta (risperidone long-acting injection). 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 法律信息 Risperdal is a registered trademark of Johnson & Johnson 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 | | PubChem化学物质编号 | 329751052 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1158 | | Risperidone impurity standard | British Pharmacopoeia (BP) Reference Standard | 1989元/25 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C23H27FN4O2 | | 分子量 | 410.48 | | MDL编号 | MFCD00274576 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | mixture | | 储存温度 | 2-8℃ | | SMILES string | CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1 | | InChI | 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 | | InChI key | RAPZEAPATHNIPO-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 + P330 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 036563 | Fluorochem | 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | 97% | 660元/250mg; 1320元/1g; 3718元/5g; 15598元/25g; | 咨询 |
基本信息 | CAS Number | 106266-06-2 | | MDL Number | MFCD00274576 |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H301: Toxic if swallowed. H311: Toxic in contact with skin. H331: Toxic if inhaled.
| | 防范说明 | P260: Do not breathe . P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P311: Call a POISON CENTER or doctor/physician. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P322: Specific measures (see . on this label). P330: Rinse mouth. P361: Remove/Take off immediately all contaminated clothing. P363: Wash contaminated clothing before reuse. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|